Medications

Record French fine for pharma giants over eye drug

The French competition authority (AFC) on Thursday slapped a record 444 million euro ($500 million) fine on pharma groups Novartis, Roche and Genentech over market abuses in sales of macular degeneration drugs.

Diseases, Conditions, Syndromes

US backs Roche's virus-flu differentiation test

Swiss pharmaceuticals giant Roche said Friday it had received the green light in the United States for emergency use of a diagnostic test differentiating between coronavirus and influenza.

Diseases, Conditions, Syndromes

Roche, Regeneron partner on coronavirus antibody cocktail

Swiss pharmaceuticals giant Roche joined forces Wednesday with Regeneron to scale up supply of the US firm's REGN-COV2 medicine—potentially both a prevention and treatment for COVID-19 infection.

Diseases, Conditions, Syndromes

Roche wins US clearance for virus treatment test

Swiss pharmaceuticals giant Roche said Thursday the US authorities had given it emergency clearance for a test identifying patients most at risk of a dangerous immune response to coronavirus infection.

Diseases, Conditions, Syndromes

Roche eyes COVID-19 antibody test launch in May

Swiss pharmaceutical giant Roche said Friday it had developed an antibody test that it hopes to roll out in May to detect people previously infected with COVID-19, even those who displayed no symptoms.

Health

Young drinkers more 'selfie-conscious,' research suggests

Young Australians are less likely to over-indulge in booze and illicit drugs because they like to keep up appearances in their social media-sphere, according to a Flinders University expert on substance abuse and addiction.

Genetics

Roche to buy US gene therapy group Spark for $4.3 bn

Swiss pharmaceuticals giant Roche said Monday it reached a deal worth $4.3 billion (3.7 billion euros) to buy US group Spark Therapeutics, which specialises in the development of gene therapy drugs.

page 2 from 7